Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Association of IgG4 response and autoimmune pancreatitis with intraductal papillary-mucinous neoplasms.

Hedayat AA, Lisovsky M, Suriawinata AA, Longnecker DS.

Pancreatology. 2017 Mar - Apr;17(2):263-266. doi: 10.1016/j.pan.2017.02.004. Epub 2017 Feb 8.

PMID:
28215485
2.

A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting.

Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.

3.

American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines.

Conwell DL, Lee LS, Yadav D, Longnecker DS, Miller FH, Mortele KJ, Levy MJ, Kwon R, Lieb JG, Stevens T, Toskes PP, Gardner TB, Gelrud A, Wu BU, Forsmark CE, Vege SS.

Pancreas. 2014 Nov;43(8):1143-62. doi: 10.1097/MPA.0000000000000237.

4.

The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition.

Stan RV, Tse D, Deharvengt SJ, Smits NC, Xu Y, Luciano MR, McGarry CL, Buitendijk M, Nemani KV, Elgueta R, Kobayashi T, Shipman SL, Moodie KL, Daghlian CP, Ernst PA, Lee HK, Suriawinata AA, Schned AR, Longnecker DS, Fiering SN, Noelle RJ, Gimi B, Shworak NW, Carrière C.

Dev Cell. 2012 Dec 11;23(6):1203-18. doi: 10.1016/j.devcel.2012.11.003.

5.

AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.

Norris AM, Gore A, Balboni A, Young A, Longnecker DS, Korc M.

Oncogene. 2013 Aug 15;32(33):3867-76. doi: 10.1038/onc.2012.394. Epub 2012 Sep 3.

6.

Invasive mucinous cystic neoplasms of the pancreas.

Baker ML, Seeley ES, Pai R, Suriawinata AA, Mino-Kenudson M, Zamboni G, Klöppel G, Longnecker DS.

Exp Mol Pathol. 2012 Dec;93(3):345-9. doi: 10.1016/j.yexmp.2012.07.005. Epub 2012 Aug 10.

PMID:
22902940
7.

PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts.

Deharvengt SJ, Tse D, Sideleva O, McGarry C, Gunn JR, Longnecker DS, Carriere C, Stan RV.

J Cell Mol Med. 2012 Nov;16(11):2690-700. doi: 10.1111/j.1582-4934.2012.01587.x.

8.

Acute pancreatitis accelerates initiation and progression to pancreatic cancer in mice expressing oncogenic Kras in the nestin cell lineage.

Carrière C, Young AL, Gunn JR, Longnecker DS, Korc M.

PLoS One. 2011;6(11):e27725. doi: 10.1371/journal.pone.0027725. Epub 2011 Nov 28.

9.

Autoimmune pancreatitis (AIP) type 1 and type 2: an international consensus study on histopathologic diagnostic criteria.

Zhang L, Chari S, Smyrk TC, Deshpande V, Klöppel G, Kojima M, Liu X, Longnecker DS, Mino-Kenudson M, Notohara K, Rodriguez-Justo M, Srivastava A, Zamboni G, Zen Y.

Pancreas. 2011 Nov;40(8):1172-9. doi: 10.1097/MPA.0b013e318233bec5.

PMID:
21975436
10.

Deletion of Rb accelerates pancreatic carcinogenesis by oncogenic Kras and impairs senescence in premalignant lesions.

Carrière C, Gore AJ, Norris AM, Gunn JR, Young AL, Longnecker DS, Korc M.

Gastroenterology. 2011 Sep;141(3):1091-101. doi: 10.1053/j.gastro.2011.05.041. Epub 2011 May 27.

11.

MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.

Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE, Longnecker DS, Gutmann EJ, Sempere LF, Korc M.

Clin Cancer Res. 2011 Sep 1;17(17):5812-21. doi: 10.1158/1078-0432.CCR-11-0695. Epub 2011 Jun 7.

12.

Intracellular activation of trypsinogen in transgenic mice induces acute but not chronic pancreatitis.

Gaiser S, Daniluk J, Liu Y, Tsou L, Chu J, Lee W, Longnecker DS, Logsdon CD, Ji B.

Gut. 2011 Oct;60(10):1379-88. doi: 10.1136/gut.2010.226175. Epub 2011 Apr 6.

13.

Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions.

Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G.

J Gastroenterol. 2010 Aug;45(8):787-93. doi: 10.1007/s00535-010-0265-x. Epub 2010 Jun 12. Review.

PMID:
20549251
14.

The diagnosis of autoimmune pancreatitis: a Western perspective.

Chari ST, Longnecker DS, Klöppel G.

Pancreas. 2009 Nov;38(8):846-8. doi: 10.1097/MPA.0b013e3181bba281. No abstract available.

PMID:
19855232
15.

Ras activity levels control the development of pancreatic diseases.

Ji B, Tsou L, Wang H, Gaiser S, Chang DZ, Daniluk J, Bi Y, Grote T, Longnecker DS, Logsdon CD.

Gastroenterology. 2009 Sep;137(3):1072-82, 1082.e1-6. doi: 10.1053/j.gastro.2009.05.052. Epub 2009 Jun 6. Erratum in: Gastroenterology. 2011 May;140(5):1696.

16.

Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.

Carrière C, Young AL, Gunn JR, Longnecker DS, Korc M.

Biochem Biophys Res Commun. 2009 May 8;382(3):561-5. doi: 10.1016/j.bbrc.2009.03.068. Epub 2009 Mar 16.

17.

Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia.

Seeley ES, Carrière C, Goetze T, Longnecker DS, Korc M.

Cancer Res. 2009 Jan 15;69(2):422-30. doi: 10.1158/0008-5472.CAN-08-1290.

18.

Growing colorectal tumors: minimizing microbial and stromal competition and assessing in vitro selection pressures.

Farrell TM, Pettengill OS, Longnecker DS, Cate CC, Cohn KH.

Cytotechnology. 2000 Nov;34(3):205-11. doi: 10.1023/A:1008131428992.

19.

Prognosis of invasive intraductal papillary mucinous neoplasm.

Longnecker DS, Klöppel G.

Pancreas. 2008 Oct;37(3):333; author reply 333-4. doi: 10.1097/mpa.0b013e31816a4f1d. No abstract available.

PMID:
18815559
20.

The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia.

Carrière C, Seeley ES, Goetze T, Longnecker DS, Korc M.

Proc Natl Acad Sci U S A. 2007 Mar 13;104(11):4437-42. Epub 2007 Mar 5.

21.

Solid serous adenoma of the pancreas: a rare variant within the family of pancreatic serous cystic neoplasms.

Reese SA, Traverso LW, Jacobs TW, Longnecker DS.

Pancreas. 2006 Jul;33(1):96-9.

PMID:
16804417
22.

Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.

Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, Pérez-Gallego L, Redston M, Tuveson DA.

Cancer Res. 2006 Jan 1;66(1):95-106.

23.
24.

Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement.

Longnecker DS, Adsay NV, Fernandez-del Castillo C, Hruban RH, Kasugai T, Klimstra DS, Klöppel G, Lüttges J, Memoli VA, Tosteson TD, Yanagisawa A, Wilentz R, Zamboni G.

Pancreas. 2005 Nov;31(4):344-9.

PMID:
16258368
25.

Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Furukawa T, Klöppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, Hruban RH, Kato Y, Klimstra DS, Longnecker DS, Lüttges J, Offerhaus GJ, Shimizu M, Sunamura M, Suriawinata A, Takaori K, Yonezawa S.

Virchows Arch. 2005 Nov;447(5):794-9. Epub 2005 Aug 9.

PMID:
16088402
26.

An experimental model of autoimmune pancreatitis in the rat.

Davidson TS, Longnecker DS, Hickey WF.

Am J Pathol. 2005 Mar;166(3):729-36.

27.

Endocrine Tumors of the Pancreas in Transgenic Mice.

Longnecker DS.

Comp Med. 2004 Feb;54(1):21-2. Review. No abstract available.

PMID:
15382338
28.

Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.

Longnecker DS.

Comp Med. 2004 Feb;54(1):18-21. Review. No abstract available.

PMID:
15382335
29.

An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Klöppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus GJ, Shimizu M, Yonezawa S.

Am J Surg Pathol. 2004 Aug;28(8):977-87. Review.

PMID:
15252303
30.

Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist?

Pearson RK, Longnecker DS, Chari ST, Smyrk TC, Okazaki K, Frulloni L, Cavallini G.

Pancreas. 2003 Jul;27(1):1-13. No abstract available.

PMID:
12826899
31.

Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.

Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP.

Cancer Res. 2003 May 1;63(9):2016-9.

32.

The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.

Adsay NV, Merati K, Andea A, Sarkar F, Hruban RH, Wilentz RE, Goggins M, Iocobuzio-Donahue C, Longnecker DS, Klimstra DS.

Mod Pathol. 2002 Oct;15(10):1087-95.

33.

Controversies in clinical pancreatology: intraductal papillary-mucinous tumor (IPMT): American Pancreatic Association Clinical Symposium.

Pearson RK, Clain JE, Longnecker DS, Reber HA, Steinberg WM, Barkin JS, Bradley EL 3rd, DiMagno E, Layer P.

Pancreas. 2002 Oct;25(3):217-21. No abstract available.

PMID:
12370530
34.

Deoxyribonuclease IIalpha is required during the phagocytic phase of apoptosis and its loss causes perinatal lethality.

Krieser RJ, MacLea KS, Longnecker DS, Fields JL, Fiering S, Eastman A.

Cell Death Differ. 2002 Sep;9(9):956-62.

35.

Abnormal methyl metabolism in pancreatic toxicity and diabetes.

Longnecker DS.

J Nutr. 2002 Aug;132(8 Suppl):2373S-2376S. doi: 10.1093/jn/132.8.2373S. Review.

PMID:
12163695
36.

Mixed acinar-endocrine carcinoma arising in the ampulla of Vater.

Moncur JT, Lacy BE, Longnecker DS.

Hum Pathol. 2002 Apr;33(4):449-51.

PMID:
12055683
37.

Effect of hypergastrinemia on pancreatic carcinogenesis.

McDonald JM, Longnecker DS, Bell RH Jr.

Am J Surg. 2002 Apr;183(4):441-4.

PMID:
11975934
38.

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN, Kern SE, Klimstra DS, Klöppel G, Longnecker DS, Lüttges J, Offerhaus GJ.

Am J Surg Pathol. 2001 May;25(5):579-86.

PMID:
11342768
39.

Simultaneous mucinous cystadenoma of ovary and mucinous cystadenocarcinoma of pancreas.

Gagne LJ, Colacchio T, Longnecker DS.

Int J Pancreatol. 2000 Aug;28(1):9-13.

PMID:
11185714
40.
41.

Vascular structure and microcirculation of experimental pancreatic carcinoma in rats.

Schmidt J, Ryschich E, Daniel V, Herzog L, Werner J, Herfarth C, Longnecker DS, Gebhard MM, Klar E.

Eur J Surg. 2000 Apr;166(4):328-35.

PMID:
10817332
42.

Role of the basic helix-loop-helix transcription factor p48 in the differentiation phenotype of exocrine pancreas cancer cells.

Adell T, Gómez-Cuadrado A, Skoudy A, Pettengill OS, Longnecker DS, Real FX.

Cell Growth Differ. 2000 Mar;11(3):137-47.

43.
44.

Molecular pathology of invasive carcinoma.

Longnecker DS.

Ann N Y Acad Sci. 1999 Jun 30;880:74-82. Review.

PMID:
10415852
45.

Hyperplastic and metaplastic changes in pancreatic ducts: nomenclature and preneoplastic potential.

Klöppel G, Longnecker DS.

Ann N Y Acad Sci. 1999 Jun 30;880:66-73. Review. No abstract available.

PMID:
10415851
46.

Observations on the etiology and pathogenesis of intraductal papillary-mucinous neoplasms of the pancreas.

Longnecker DS.

Hepatogastroenterology. 1998 Nov-Dec;45(24):1973-80. Review.

PMID:
9951850
47.

Mechanistic analysis and chemoprevention of pancreatic carcinogenesis.

Konishi Y, Tsutsumi M, Longnecker DS.

Pancreas. 1998 Nov;17(4):334-40.

PMID:
9821174
48.

What is the true rate of K-ras mutation in carcinoma of the pancreas?

Longnecker DS, Terhune PG.

Pancreas. 1998 Nov;17(4):323-4. Review. No abstract available.

PMID:
9821172
49.

K-ras mutation in focal proliferative lesions of human pancreas.

Terhune PG, Phifer DM, Tosteson TD, Longnecker DS.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):515-21.

50.

Azaserine-induced rat pancreas tumor model with transplantable cultured cells.

Mäkinen K, Loimas S, Kosma VM, Wahlfors J, Pettengill OS, Longnecker DS, Johansson R, Alhava E.

Pancreas. 1998 Mar;16(2):160-4.

PMID:
9510139

Supplemental Content

Loading ...
Support Center